亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

左旋舒必利 CAS 號(hào):23672-07-3

 
 
單價(jià) 面議對(duì)比
詢價(jià) 暫無(wú)
發(fā)貨 湖北隨州市付款后3天內(nèi)
型號(hào) 23672-07-3
過(guò)期 長(zhǎng)期有效
更新 2020-07-28 08:59
 

隨州市紅旗化工有限公司

企業(yè)會(huì)員第15年
資料未認(rèn)證
保證金未繳納
  • 湖北-隨州市
  • 上次登錄 2023-06-07
  • 閆先生 (先生)   經(jīng)理
詳細(xì)說(shuō)明
左旋舒必利
CAS 號(hào):23672-07-3
中文同義詞: (S)-(-)-5-氨基磺酰-N-[(1-乙基-2-四氫吡咯基)甲基]-2-甲氧基苯甲酰胺;左旋舒必利;(S)-(-)-N-[甲基-(1-乙基-2-吡咯烷基)]-2-甲氧基-5-(氨基磺?;?-苯甲酰胺;左舒必利;(S)-(-)-5-(氨基磺?;?-N-[(1-乙基-2-吡咯烷基)甲基]-2-甲氧基苯甲酰胺;(S)-(-)-舒必利;(S)-5-氨基磺酰-N-[(1-乙基-2-吡咯烷基)甲基]-2-甲氧基苯酰胺
英文名稱: Levosulpiride
英文同義詞: (S)-(-)-SULPIRIDE;(S)-(-)-5-AMINOSULFONYL-N-[(1-ETHYL-2-PYRROLIDINYL)METHYL]-2-METHOXYBENZAMIDE;(S)-5-AMINOSULFONYL-N-[(1-ETHYL-2-PYRROLIDINYL)METHYL]-2-METHOXYBENZAMIDE;(-)-N-1-[ETHYLPYRROLIDIN-2-YLMETHYL]-2-METHOXY-5-SULFAMOYLBENZAMIDE;(s)-(-)-n-((1-ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl-o-anisamide;(s)-(-)-o-anisamid;5-(aminosulfonyl)-n-((1-ethyl-2-pyrrolidinyl)methyl)-2-methoxy-benzamid(;levopraid
分子量: 341.4
 
分子式: C15H23N3O4S
 規(guī)格:98.5~101.1%
 標(biāo)準(zhǔn):CP2005
外觀:性狀:本品為白色或米白色結(jié)晶形粉末,無(wú)味道,不溶于水,易溶于乙酸及0.5N禁發(fā) 硫酸,溶于甲醇、二甲基甲酰胺。
 用途:本品為一種抗精神病藥,治療神經(jīng)分裂癥,也用于頑固性嘔吐、消化性潰瘍及腦外傷后的眩暈頭痛。
包裝規(guī)格:25kg/桶
舉報(bào)收藏 0評(píng)論 0
更多>本企業(yè)其它產(chǎn)品
來(lái)氟米特 CAS號(hào): 75706-12-6 頭孢曲松鈉 CAS;74578-69-1 福多斯坦 CAS號(hào): 13189-98-5 克洛索隆 CAS;60200-06-8 磷酸吡哆醛 CAS號(hào): 54-47-7 4-甲基噻唑-5-甲醛 CAS號(hào): 82294-70-0 三氯苯噠唑 CAS:68786-66-3 5-乙酰水楊酸甲酯 CAS;16475-90-4
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |